Not all compounds are suitable starting points for drug development due to undesirable pharmacokinetic properties, which for instance negatively affect a drug's absorption, distribution, metabolism, and excretion (ADME). Therefore, such compounds are usually not included in data sets for virtual screening. This workflow shows how to remove less drug-like molecules from a data set using Lipinski's rule of five.
Used extensions & nodes
Created with KNIME Analytics Platform version 4.5.0 Note: Not all extensions may be displayed.
By using or downloading the workflow, you agree to our terms and conditions.
Discussions are currently not available, please try again later.